Pay in 4 interest-free payments of $6.53 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
We found that GLP-1 agonists were associated with decreased risk of psychiatric hospitalizations and sick leaves due to psychiatric reasons in people with depression and/ or anxiety disorders
Every TrufaMED IV is physician-ordered and prepared by a licensed provider in a Joint Commission accredited clinic
TRIUMPH-4 demonstrated 28.7% average weight loss at 68 weeks (December 2025)
Assuming a 10% GLP-1 usage rate among overweight adults and a 20% usage rate among obese adults in the U.S., Roe (2025) estimates this could lead to a 3% reduction in total caloric demand, which amounts to 20 billion fewer calories of food consumed per day and about $1.2 billion less spent per week
Elevate your projects with reliable, rigorously tested products backed by scientific expertise
Transparent formulation with no unnecessary additives
US$ 28.40
US$ 28.71
US$ 23.51
US$ 21.84
